Franklin Resources Inc. Acquires 343,287 Shares of Veeva Systems Inc. $VEEV

Franklin Resources Inc. increased its holdings in Veeva Systems Inc. (NYSE:VEEV) by 24.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,729,436 shares of the technology company’s stock after purchasing an additional 343,287 shares during the period. Franklin Resources Inc. owned approximately 1.06% of Veeva Systems worth $515,216,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in VEEV. Sivia Capital Partners LLC grew its stake in shares of Veeva Systems by 225.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock valued at $899,000 after purchasing an additional 2,164 shares during the period. Vestmark Advisory Solutions Inc. bought a new position in shares of Veeva Systems during the 2nd quarter worth approximately $297,000. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Veeva Systems in the 2nd quarter valued at $8,520,000. Allworth Financial LP boosted its stake in Veeva Systems by 1,070.1% in the 2nd quarter. Allworth Financial LP now owns 9,934 shares of the technology company’s stock valued at $2,861,000 after buying an additional 9,085 shares in the last quarter. Finally, Vise Technologies Inc. bought a new stake in Veeva Systems in the second quarter valued at $392,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

Insider Buying and Selling

In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the sale, the insider owned 23,204 shares of the company’s stock, valued at $5,370,101.72. This represents a 4.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 10.30% of the stock is currently owned by corporate insiders.

Veeva Systems Stock Performance

Veeva Systems stock opened at $186.96 on Thursday. The firm has a market cap of $30.73 billion, a P/E ratio of 34.56, a P/E/G ratio of 1.31 and a beta of 1.09. The business’s fifty day moving average is $201.48 and its two-hundred day moving average is $245.18. Veeva Systems Inc. has a 52 week low of $168.13 and a 52 week high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The company had revenue of $835.95 million for the quarter, compared to analysts’ expectations of $810.95 million. During the same quarter in the prior year, the business earned $1.74 earnings per share. The business’s revenue for the quarter was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, equities research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Veeva Systems declared that its Board of Directors has initiated a share buyback program on Monday, January 5th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the technology company to repurchase up to 5.5% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its shares are undervalued.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva acquired AI chat specialist Ostro for roughly $100M to add an AI-driven, compliant brand‑engagement chat tool for patients and HCPs — expands Commercial Cloud capabilities and product moat. Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
• Positive Sentiment: AOP Health standardized on Veeva’s Industry Cloud across R&D, quality, commercial and data — a notable customer win that supports recurring SaaS revenue and cross‑cloud adoption. AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
• Positive Sentiment: Q4 results beat expectations with stronger demand for modernization (safety, R&D) and expansion among top 20 pharma customers; management emphasized scalable, automated core systems as the main growth driver. These fundamentals support revenue durability and the long‑term SaaS upsell story. 5 Revealing Analyst Questions From Veeva Systems’s Q4 Earnings Call
• Neutral Sentiment: Analyst/investor attention articles (Zacks, market commentary) highlight interest in Veeva but don’t add new material facts — they may increase trading volume but are unlikely alone to change fundamentals. Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
• Negative Sentiment: Citigroup lowered its expectations/price target for Veeva, signaling analyst concern that recent moves (acquisition spend, guidance cadence) or valuation may not justify current multiples — analyst downgrades can pressure the stock near term. Citigroup Has Lowered Expectations for Veeva Systems (NYSE:VEEV) Stock Price

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. BTIG Research reiterated a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research note on Friday, November 21st. KeyCorp restated a “sector weight” rating on shares of Veeva Systems in a research note on Friday, December 12th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $330.00 target price on shares of Veeva Systems in a report on Monday, November 24th. Stifel Nicolaus increased their target price on shares of Veeva Systems from $212.00 to $245.00 and gave the stock a “buy” rating in a research report on Thursday, March 5th. Finally, Citigroup cut their price target on shares of Veeva Systems from $319.00 to $291.00 and set a “buy” rating for the company in a report on Monday. Seventeen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $283.70.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.